Published online Nov 12, 2013. doi: 10.5499/wjr.v3.i3.40
Revised: July 4, 2013
Accepted: July 17, 2013
Published online: November 12, 2013
Core tip: Coexistence of inflammatory rheumatological diseases and lymphedema is an under-recognized subject. Drawing clinicians’ attention to this issue is important for improving patients’ quality of life. In patients with inflammatory rheumatological disease and lymphedema, although the complex decongestive therapy method is the primary approach, tumor necrosis factor-α inhibitors mentioned in the literature, whose efficacy requires explanation, may also be tried.